Market news

AARD Stock News: Robbins LLP Reminds Aardvark Therapeutics, Inc. Stockholders to Contact the Firm Be...

Topics

AARD Stock News: Robbins LLP Reminds Aardvark Therapeutics, Inc. Stockholders to Contact the Firm Before the October 13, 2026 Lead Plaintiff Deadline SAN DIEGO, Sept. 30, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) (a) common stock pursuant to the Company's February 13, 2025 initial public offering ("IPO") and/or (b) securities between February 13, 2025 and May 14, 2026 (the "Class Period").

QATS is not a registered broker-dealer or investment advisor. All strategies are created and managed by users. Trading involves risk, and past performance is not indicative of future results. QATS does not store or manage user funds. All trades are executed via official broker APIs. Users must be 18 years or older to use the platform.

Maurizio Vitalle 3

© 2026 Quant Algorithm Tree System Ltd.

A better experience starts with cookies

Your data, your choice. We use cookies to improve how things work here.

Cookie policy